Advertisement

Ovarian Cancer pp 147-163 | Cite as

Aberrant Epithelial Differentiation in Ovarian Cancer

  • Elizabeth R. Smith
  • Kathy Qi Cai
  • Callinice D. Capo-chichi
  • Xiang- Xi Xu
Chapter
Part of the Cancer Treatment and Research book series (CTAR, volume 149)

Introduction

It is well recognized that cancer cells often appear in an inappropriately differentiated stage, and the term “dedifferentiation” is often used.1, 2, 3, 4 Dedifferentiation is a prominent feature of cancer cells; however, the causative mechanism is not well understood. Even the meaning of “dedifferentiation” is not well defined and is often used to refer to various aspects of cell changes associated with neoplastic transformation. The phenotype of ovarian cancer described as “undifferentiated” or “dedifferentiated” often refers to the apparent changes of the cancer cells toward a less epithelial-like morphology. However, such a definition is subjective and lacks molecular determinants.

To provide a molecular interpretation of “dedifferentiation” of cancer cells, one may consider the concept of cell lineage differentiation prominent in developmental biology, in which a primordial cell undergoes change in its global gene expression profile toward a specific mature cell type....

Keywords

Ovarian Cancer Cancer Stem Cell Ovarian Cancer Cell Ovarian Cancer Cell Line Ovarian Surface Epithelium 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgments

We acknowledge the excellent technical assistance from Jennifer Smedberg and Malgorzata Rula in the laboratory research that produced the results cited in this chapter. We are grateful to the laboratory members for their suggestions, comments, and reading and editing during the course of the experiments and preparation of the manuscript. These studies were supported by funds from grants R01 CA095071, CA79716, and CA75389 to X.X. Xu from NCI, NIH.

References

  1. 1.
    Fusenig NE, Breitkreutz D, Boukamp P, Tomakidi P, Stark HJ. Differentiation and tumor progression. Recent Results Cancer Res. 1995;139:1–19.PubMedGoogle Scholar
  2. 2.
    Lynch RG. Differentiation and cancer: the conditional autonomy of phenotype. Proc Natl Acad Sci USA. 1995;92:647–648.CrossRefPubMedGoogle Scholar
  3. 3.
    Rheinwald JG, Beckett MA. Defective terminal differentiation in culture as a consistent and selectable character of malignant human keratinocytes. Cell. 1980;22:629–632.CrossRefPubMedGoogle Scholar
  4. 4.
    Richardson GS, Scully RE, Nikrui N, Nelson JH Jr. Common epithelial cancer of the ovary (2). N Engl J Med. 1985;312:474–483.CrossRefPubMedGoogle Scholar
  5. 5.
    Capo-chichi CD, Roland IH, Vanderveer L, et al. Anomalous expression of epithelial differentiation-determining GATA factors in ovarian tumorigenesis. Cancer Res. 2003;63:4967–4977.PubMedGoogle Scholar
  6. 6.
    Caslini C, Capo-Chichi CD, Roland IH, Nicolas E, Yeung AT, Xu XX. Histone modifications silence the GATA transcription factor genes in ovarian cancer. Oncogene. 2006;25:5446–5461.CrossRefPubMedGoogle Scholar
  7. 7.
    Bielinska M, Narita N, Wilson DB. Distinct roles for visceral endoderm during embryonic mouse development. Int J Dev Biol. 1999;43:183–205.PubMedGoogle Scholar
  8. 8.
    Lu CC, Brennan J, Robertson EJ. From fertilization to gastrulation: axis formation in the mouse embryo. Curr Opin Genet Dev. 2001;11:384–392.CrossRefPubMedGoogle Scholar
  9. 9.
    Capo-Chichi CD, Rula ME, Smedberg JL, Vanderveer L, Parmacek MS, Morrisey EE, Godwin AK, Xu XX. Perception of differentiation cues by GATA factors in primitive endoderm lineage determination of mouse embryonic stem cells. Dev Biol. 2005;286:574–586.CrossRefPubMedGoogle Scholar
  10. 10.
    Molkentin JD. The zinc finger-containing transcription factors GATA-4, -5, and -6. Ubiquitously expressed regulators of tissue-specific gene expression. J Biol Chem . 2000;275:38949–38952.CrossRefPubMedGoogle Scholar
  11. 11.
    Orkin SH. GATA-binding transcription factors in hematopoietic cells. Blood. 1992;80:575–581.PubMedGoogle Scholar
  12. 12.
    Simon MC. Gotta have GATA. Nat Genet. 1995;11:9–11.CrossRefPubMedGoogle Scholar
  13. 13.
    Soudais C, Bielinska M, Heikinheimo M, et al. Targeted mutagenesis of the transcription factor GATA-4 gene in mouse embryonic stem cells disrupts visceral endoderm differentiation in vitro. Development. 1995;121:3877–3888.PubMedGoogle Scholar
  14. 14.
    Morrisey EE, Ip HS, Lu MM, Parmacek MS. GATA-6: a zinc finger transcription factor that is expressed in multiple cell lineages derived from lateral mesoderm. Dev Biol. 1996;177:309–322.CrossRefPubMedGoogle Scholar
  15. 15.
    Fujikura J, Yamato E, Yonemura S, et al. Differentiation of embryonic stem cells is induced by GATA factors. Genes Dev. 2002;16:784–789.CrossRefPubMedGoogle Scholar
  16. 16.
    Kuo CT, Morrisey EE, Anandappa R, et al. GATA4 transcription factor is required for ventral morphogenesis and heart tube formation. Genes Dev. 1997;11:1048–1060.CrossRefPubMedGoogle Scholar
  17. 17.
    Watt AJ, Zhao R, Li J, Duncan SA. Development of the mammalian liver and ventral pancreas is dependent on GATA4. BMC Dev Biol. 2007;7:37.CrossRefPubMedGoogle Scholar
  18. 18.
    Yang H, Lu MM, Zhang L, Whitsett JA, Morrisey EE. GATA6 regulates differentiation of distal lung epithelium. Development. 2002;129:2233–2246.CrossRefPubMedGoogle Scholar
  19. 19.
    Jacobsen CM, Narita N, Bielinska M, Syder AJ, Gordon JI, Wilson DB. Genetic mosaic analysis reveals that GATA-4 is required for proper differentiation of mouse gastric epithelium. Dev Biol. 2002;241:34–46.CrossRefPubMedGoogle Scholar
  20. 20.
    Gao X, Sedgwick T, Shi YB, Evans T. Distinct functions are implicated for the GATA-4, -5, and -6 transcription factors in the regulation of intestine epithelial cell differentiation. Mol Cell Biol. 1998;18:2901–2911.PubMedGoogle Scholar
  21. 21.
    Ketola I, Rahman N, Toppari J, et al. Expression and regulation of transcription factors GATA-4 and GATA-6 in developing mouse testis. Endocrinology. 1999;140:1470–1480.CrossRefPubMedGoogle Scholar
  22. 22.
    Heikinheimo M, Ermolaeva M, Bielinska M, et al. Expression and hormonal regulation of transcription factors GATA-4 and GATA-6 in the mouse ovary. Endocrinology. 1997;138:3505–3514.CrossRefPubMedGoogle Scholar
  23. 23.
    Laitinen MP, Anttonen M, Ketola I, Wilson DB, Ritvos O, Butzow R, Heikinheimo M. Transcription factors GATA-4 and GATA-6 and a GATA family cofactor, FOG-2, are expressed in human ovary and sex cord-derived ovarian tumors. J Clin Endocrinol Metab. 2000;85:3476–3483.CrossRefPubMedGoogle Scholar
  24. 24.
    Asselin-Labat ML, Sutherland KD, Barker H, et al. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat Cell Biol. 2007;9:201–209.CrossRefPubMedGoogle Scholar
  25. 25.
    Kouros-Mehr H, Slorach EM, Sternlicht MD, Werb Z. GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell. 2006;127:1041–1055.CrossRefPubMedGoogle Scholar
  26. 26.
    Fazili Z, Sun W, Mittelstaedt S, Cohen C, Xu XX. Disabled-2 inactivation is an early step in ovarian tumorigenicity. Oncogene. 1999;18:3104–3113.CrossRefPubMedGoogle Scholar
  27. 27.
    Morrisey EE, Musco S, Chen MY, Lu MM, Leiden JM, Parmacek MS. The gene encoding the mitogen-responsive phosphoprotein Dab2 is differentially regulated by GATA-6 and GATA-4 in the visceral endoderm. J Biol Chem. 2000;275:19949–19954.CrossRefPubMedGoogle Scholar
  28. 28.
    Yang DH, Smith ER, Cohen C, et al. Molecular events associated with dysplastic morphological transformation and initiation of ovarian tumorigenicity. Cancer. 2002;94:2380–2392.CrossRefPubMedGoogle Scholar
  29. 29.
    Sheng Z, Sun W, Smith E, Cohen C, Sheng Z, Xu XX. Restoration of positioning control following disabled-2 expression in ovarian and breast tumor cells. Oncogene. 2000;19:4847–4854.CrossRefPubMedGoogle Scholar
  30. 30.
    Bai Y, Akiyama Y, Nagasaki H, et al. Distinct expression of CDX2 and GATA4/5, development-related genes, in human gastric cancer cell lines. Mol Carcinog. 2000;28:184–188.CrossRefPubMedGoogle Scholar
  31. 31.
    Baylin S, Bestor TH. Altered methylation patterns in cancer cell genomes: cause or consequence? Cancer Cell. 2002;1:299–305.CrossRefPubMedGoogle Scholar
  32. 32.
    Kouros-Mehr H, Bechis SK, Slorach EM, et al. GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model. Cancer Cell. 2008;13:141–152.CrossRefPubMedGoogle Scholar
  33. 33.
    Kamnasaran D, Qian B, Hawkins C, Stanford WL, Guha A. GATA6 is an astrocytoma tumor suppressor gene identified by gene trapping of mouse glioma model. Proc Natl Acad Sci U S A. 2007;104:8053–8058.CrossRefPubMedGoogle Scholar
  34. 34.
    Bleau AM, Holland EC. Trapping the mouse genome to hunt human alterations. Proc Natl Acad Sci U S A. 2007;104:7737–7738.CrossRefPubMedGoogle Scholar
  35. 35.
    Wolffe AP. Chromatin and gene regulation at the onset of embryonic development. Reprod Nut Dev. 1996;36:581–606.Google Scholar
  36. 36.
    Jenuwein T, Allis CD. Translating the histone code. Science. 2001;293:1074–1080.CrossRefPubMedGoogle Scholar
  37. 37.
    Gregory PD, Wagner K, Horz W. Histone acetylation and chromatin remodeling. Exp Cell Res. 2001;265:195–202.CrossRefPubMedGoogle Scholar
  38. 38.
    Santos-Rosa H, Schneider R, Bannister AJ, et al. Active genes are tri-methylated at K4 of histone H3. Nature. 2002;419:407–411.CrossRefPubMedGoogle Scholar
  39. 39.
    Schneider R, Bannister AJ, Myers FA, Thorne AW, Crane-Robinson C, Kouzarides T. Histone H3 lysine 4 methylation patterns in higher eukaryotic genes. Nat Cell Biol. 2004;6:73–77.CrossRefPubMedGoogle Scholar
  40. 40.
    Lachner M, O'Carroll D, Rea S, Mechtler K, Jenuwein T. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature. 2001;410:116–120.CrossRefPubMedGoogle Scholar
  41. 41.
    Jones PA, Laird PW. Cancer epigenetics comes of age. Nat Genet. 1999;21:163–167.CrossRefPubMedGoogle Scholar
  42. 42.
    Herman JG, Baylin SB, N Engl J Med. 2003;349:2042–2054.Google Scholar
  43. 43.
    Hake SB, Xiao A, Allis CD. Linking the epigenetic ‘language’ of covalent histone modifications to cancer. Br J Cancer. 2004;90:761–769.CrossRefPubMedGoogle Scholar
  44. 44.
    Mutskov V, Felsenfeld G. Silencing of transgene transcription precedes methylation of promoter DNA and histone H3 lysine 9. EMBO J. 2004;23:138–149.CrossRefPubMedGoogle Scholar
  45. 45.
    Bachman KE, Park BH, Rhee I, et al. Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene. Cancer Cell. 2003;3:89–95.CrossRefPubMedGoogle Scholar
  46. 46.
    Wakana K, Akiyama Y, Aso T, Yuasa Y. Involvement of GATA-4/-5 transcription factors in ovarian carcinogenesis. Cancer Lett. 2006;241:281–288.CrossRefPubMedGoogle Scholar
  47. 47.
    Dance AL, Miller M, Seragaki S, et al. Regulation of myosin-VI targeting to endocytic compartments. Traffic. 2004;5:798–813.CrossRefPubMedGoogle Scholar
  48. 48.
    Yang DH, Cai KQ, Roland IH, Smith ER, Xu XX. Disabled-2 is an epithelial surface positioning gene. J Biol Chem. 2007;282:13114–13122.CrossRefPubMedGoogle Scholar
  49. 49.
    Capo-chichi CD, Smith ER, Yang DH, et al. Dynamic alterations of extracellular environment of ovarian surface epithelial cells in pre-malignant transformation, tumorigenicity, and metastasis. Cancer. 2002;95:1802–1815.CrossRefPubMedGoogle Scholar
  50. 50.
    Stenbeck F, Wasenius V-M. Basement membrane structures in tumors of the ovary. Eur J Obstet Gynec Reprod Biol. 1985;20:357–371.CrossRefGoogle Scholar
  51. 51.
    Rossant J. Stem cells and early lineage development. Cell. 2008;132:527–531.CrossRefPubMedGoogle Scholar
  52. 52.
    Lobo NA, Shimono Y, Qian D, Clarke MF. The biology of cancer stem cells. Annu Rev Cell Dev Biol.2007;23:675–699.CrossRefPubMedGoogle Scholar
  53. 53.
    Polyak K. Breast cancer stem cells: a case of mistaken identity? Stem Cell Rev. 2007;3:107–109.CrossRefPubMedGoogle Scholar
  54. 54.
    Bapat SA, Mali AM, Koppikar CB, Kurrey NK. Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Cancer Res. 2005;65:3025–3029.PubMedGoogle Scholar
  55. 55.
    Wani AA, Sharma N, Shouche YS, Bapat SA. Nuclear-mitochondrial genomic profiling reveals a pattern of evolution in epithelial ovarian tumor stem cells. Oncogene. 2006;25:6336–6344.CrossRefPubMedGoogle Scholar
  56. 56.
    Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, et al. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian inhibiting substance responsiveness. Proc Natl Acad Sci U S A. 2006;103:11154–11159.CrossRefPubMedGoogle Scholar
  57. 57.
    Bast RC Jr, Boyer CM, Jacobs I, et al. Cell growth regulation in epithelial ovarian cancer. Cancer. 1993;71:1597–1601.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Elizabeth R. Smith
    • 1
  • Kathy Qi Cai
    • 1
  • Callinice D. Capo-chichi
    • 1
  • Xiang- Xi Xu
    • 1
  1. 1.Department of Medicine, and Department of Obstetrics and Gynecology, UM/Sylvester Comprehensive Cancer CenterUniversity of Miami School of MedicineMiamiUSA

Personalised recommendations